Gross V - Search Results

1

Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.

Lochs H, Mayer M, Fleig WE, Mortensen PB, Bauer P, Genser D, Petritsch W, Raithel M, Hoffmann R, Gross V, Plauth M, Staun M, Nesje LB. Lochs H, et al. Among authors: gross v. Gastroenterology. 2000 Feb;118(2):264-73. doi: 10.1016/s0016-5085(00)70208-3. Gastroenterology. 2000. PMID: 10648454 Clinical Trial.

2

Low dose oral pH modified release budesonide for maintenance of steroid induced remission in Crohn's disease. The Budesonide Study Group.

Gross V, Andus T, Ecker KW, Raedler A, Loeschke K, Plauth M, Rasenack J, Weber A, Gierend M, Ewe K, Schölmerich J. Gross V, et al. Gut. 1998 Apr;42(4):493-6. doi: 10.1136/gut.42.4.493. Gut. 1998. PMID: 9616309 Free PMC article. Clinical Trial.

3

Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.

Gross V, Andus T, Caesar I, Bischoff SC, Lochs H, Tromm A, Schulz HJ, Bär U, Weber A, Gierend M, Ewe K, Schölmerich J. Gross V, et al. Eur J Gastroenterol Hepatol. 1996 Sep;8(9):905-9. Eur J Gastroenterol Hepatol. 1996. PMID: 8889459 Clinical Trial.

4

[1997 gastroenterology update--II].

Fischbach W, Gross V, Schölmerich J, Ell C, Layer P, Fleig WE. Fischbach W, et al. Among authors: gross v. Med Klin (Munich). 1998 Mar 15;93(3):146-64. doi: 10.1007/BF03044832. Med Klin (Munich). 1998. PMID: 9564162 Review. German. No abstract available.

5

Prior bowel resections, perianal disease, and a high initial Crohn's disease activity index are associated with corticosteroid resistance in active Crohn's disease.

Gelbmann CM, Rogler G, Gross V, Gierend M, Bregenzer N, Andus T, Schölmerich J. Gelbmann CM, et al. Among authors: gross v. Am J Gastroenterol. 2002 Jun;97(6):1438-45. doi: 10.1111/j.1572-0241.2002.05685.x. Am J Gastroenterol. 2002. PMID: 12094862 Clinical Trial.

6

Association of HLA-DR genotypes and IL-1ra gene polymorphism with treatment failure of budesonide and disease patterns in Crohn's disease.

Gelbmann CM, Rogler G, Gierend M, Gross V, Schölmerich J, Andus T. Gelbmann CM, et al. Among authors: gross v. Eur J Gastroenterol Hepatol. 2001 Dec;13(12):1431-7. doi: 10.1097/00042737-200112000-00006. Eur J Gastroenterol Hepatol. 2001. PMID: 11742191 Clinical Trial.

7

Replacement of conventional glucocorticoids by oral pH-modified release budesonide in active and inactive Crohn's disease: results of an open, prospective, multicenter trial.

Andus T, Gross V, Caesar I, Schulz HJ, Lochs H, Strohm WD, Gierend M, Weber A, Ewe K, Schölmerich J; German/Austrian Budesonide Study Group. Andus T, et al. Among authors: gross v. Dig Dis Sci. 2003 Feb;48(2):373-8. doi: 10.1023/a:1021900115403. Dig Dis Sci. 2003. PMID: 12643618 Clinical Trial.

8

[Crohn disease: prevention and drug therapy].

Gross V, Andus T, Schölmerich J. Gross V, et al. Chirurg. 1995 Aug;66(8):757-63. Chirurg. 1995. PMID: 7587538 Review. German.

9

Evidence for continuous stimulation of interleukin-6 production in Crohn's disease.

Gross V, Andus T, Caesar I, Roth M, Schölmerich J. Gross V, et al. Gastroenterology. 1992 Feb;102(2):514-9. doi: 10.1016/0016-5085(92)90098-j. Gastroenterology. 1992. PMID: 1370661

10

Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.

Caesar I, Gross V, Roth M, Andus T, Schmidt C, Raedsch R, Weber A, Gierend M, Ewe K, Schölmerich J. Caesar I, et al. Among authors: gross v. Hepatogastroenterology. 1997 Mar-Apr;44(14):445-51. Hepatogastroenterology. 1997. PMID: 9164517 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

359 results

Search Page